FIELD: medicine. SUBSTANCE: method involves administering dexmedomidine through an area on skin having 2.0-90 2,0-90 cm2 at rate of 0.1-200 g/h. Therapeutic system is laminated composite of reverse layer, optional adhesive layer, adhesive contact layer and one or several additional layers. EFFECT: enhanced effectiveness of dexmedomidine administration. 11 cl, 3 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE FOR TRANSDERMAL BISOPROLOL INTRODUCTION | 2008 |
|
RU2440811C2 |
| TRANSDERMAL SYSTEM FOR VARENICLINE | 2006 |
|
RU2388461C2 |
| ADHESIVE PHARMACEUTICAL BISOPROPOL-CONTAINING COMPOSITION | 2006 |
|
RU2396951C2 |
| METHODS FOR PAIN RELIEF USING DEXMEDETOMIDINE TRANSDERMAL DELIVERY DEVICES | 2017 |
|
RU2723761C1 |
| TRANSDERMAL DONEPEZIL DELIVERY SYSTEM | 2017 |
|
RU2779471C2 |
| NICOTINE TRANSDERMAL DELIVERY SYSTEM | 2006 |
|
RU2400216C2 |
| METHOD FOR MAKING PREPARATION FOR TRANSDERMAL NICOTINE INTRODUCTION | 2006 |
|
RU2403018C2 |
| TAPE-APPLIED PHENTHANYL-CONTAINING PREPARATION FOR PERCUTANEOUS USAGE | 1997 |
|
RU2194496C2 |
| AGENT AND METHOD FOR TRANSDERMAL DELIVERY OF OESTROGEN | 2009 |
|
RU2526186C2 |
| TRANSDERMAL DELIVERY OF LAZOPHOXIPHEN | 2001 |
|
RU2328276C2 |
